RxDoctor Payments Data

Brittany Fox, PA

Physician Assistant · Athens, GANPI 1598100232

Payments from drug & device makers

$6,343in general payments, 2019–2025

Across 287 payments — averaging $22.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$854
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$618
  • Biotronik NRO, Inc.$548
  • Collegium Pharmaceutical, Inc.$481
  • Forte Bio-pharma LLC$331
  • plus $2K from 22 others

What the payments were for

  • Travel & lodging$1,02716%
  • Food & beverage$5,30184%
  • Education$160%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,343 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$5,098
Medicare patients
31
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RelistorMethylnaltrexone Bromide35$83,926
ZtlidoLidocaine81$78,094
MovantikNaloxegol Oxalate65$25,739
LinzessLinaclotide35$18,401
BelbucaBuprenorphine Hcl14$10,905
Lidocaine62$9,541
Gabapentin507$5,131
Diclofenac Sodium107$3,796
Buprenorphine12$3,591
Tizanidine Hcl350$2,138
Methocarbamol214$2,058
Chlorzoxazone59$2,003
Lidocaine-PrilocaineLidocaine/Prilocaine54$1,669
Baclofen115$1,193
Naloxone Hcl17$1,052

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$618$83,92635 claims
Scilex Pharmaceuticals Inc.Ztlido$327$78,09481 claims
Redhill Biopharma Inc.Movantik$12$25,73965 claims
AbbVieLinzess$145$18,40135 claims
Collegium Pharmaceutical, Inc.Belbuca$481$10,90514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →